Fumaric Acid

Fumaric Acid

SCHEMBL9864009

CCC(C)(O)CC(N)C1(c2ccc(Cl)cc2)CCC1.O=C(O)C=CC(=O)O

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 known ✓ P31645 13/20 0.51
SLC6A3 known ✓ Q01959 12/20 0.51
SLC6A2 known ✓ P23975 5/20 0.39
CHRM2 known ✓ P08172 1/20 0.37
ADRA2A known ✓ P08913 1/20 0.37
ADRA2B known ✓ P18089 1/20 0.37
ADRA2C known ✓ P18825 1/20 0.37
HTR2A known ✓ P28223 1/20 0.37
HTR2B known ✓ P41595 1/20 0.37
KCNH2 known ✓ Q12809 1/20 0.37
MEN1 known ✓ O00255 1/20 0.32
KMT2A known ✓ Q03164 1/20 0.32
CYP3A4 P08684 3/20 0.48
ALOX15 P16050 2/20 0.48
TSHR P16473 2/20 0.48
TP53 P04637 1/20 0.48
OPRK1 P41145 1/20 0.37
LMNA P02545 2/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL9863998 1.00 SLC6A4 (0.51) SLC6A4SLC6A3CYP3A4ALOX15TSHR
SCHEMBL9863950 0.91 SLC6A4 (0.61) SLC6A4SLC6A3CYP3A4ALOX15TSHR
Maleic Acid SCHEMBL9864047 0.90 SLC6A4 (0.51) SLC6A4SLC6A3CYP3A4ALOX15TSHR
Fumaric Acid SCHEMBL9864056 0.90 SLC6A4 (0.51) SLC6A4SLC6A3CYP3A4ALOX15TSHR
SCHEMBL9864068 0.81 SLC6A4 (0.58) SLC6A4SLC6A3CYP3A4ALOX15TSHR
SCHEMBL9864232 0.81 SLC6A4 (0.58) SLC6A4SLC6A3CYP3A4ALOX15TSHR
SCHEMBL9863748 0.81 SLC6A4 (0.42) SLC6A4SLC6A3CYP3A4ALOX15TSHR
SCHEMBL9863883 0.80 CYP3A4 (0.63) SLC6A4SLC6A3CYP3A4ALOX15TSHR
SCHEMBL9864044 0.80 SLC6A4 (0.62) SLC6A4SLC6A3CYP3A4ALOX15TSHR
SCHEMBL5668946 0.79 SLC6A4 (0.61) SLC6A4SLC6A3CYP3A4ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5047432-A Antidepressants THE BOOTS COMPANY PLC (GB) 1991-09-10 US disclosed
US-4925879-A ANTIDEPRESSANTS BOOTS COMPANY, PLC (GB) 1990-05-15 US disclosed
EP-0191542-B1 ARYLCYCLOBUTYLALKYL AMINES AND THEIR USE AS ANTIDEPRESSIVE MEDICINES The Boots Company PLC (GB) 1988-06-08 EP disclosed
EP-0191542-A1 Arylcyclobutylalkyl amines and their use as antidepressive medicines The Boots Company PLC (GB) 1986-08-20 EP disclosed